Abstract
Recent changes in treatment of allergic rhinitis have not demonstrated a treatment that is clearly superior to any of the others. My own personal experience has suggested that intranasal topical steroids are the most effective treatment of allergic nasal disease, but minor limitations associated with this form of therapy make its universal use as a primary treatment of allergic rhinitis somewhat questionable. The newer antihistamines are without significant side effects, but require improved efficacy. This will likely occur in the near future. As for immunotherapy, recent immunological modifications of vaccines have not yet provided the clinician with improved efficacy.
Get full access to this article
View all access options for this article.
